Actinium Pharmaceuticals

ATNM

NYSE MKT LLCHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-42.12M

EBITDA$-37.43M

EBIT$-38.24M

Pre-tax Income$-23.47M

Net Income$-38.24M

Cash Equivalent$80.41M

Total Debt$1.78M

Book Value$39.66M

Book Value Per Share1.31

Return on Equity (ROE)-116.74%

Return on Assets (ROA)-49.73%

Return on Invested Capital (ROI)-116.67%

Net Profit Margin-60269.14%

Current Ratio9.14

Quick Ratio8.95

Long-Term Debt / Equitynull